BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12554526)

  • 1. Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
    Misawa A; Hosoi H; Tsuchiya K; Iehara T; Sawada T; Sugimoto T
    Pediatr Hematol Oncol; 2003 Mar; 20(2):151-5. PubMed ID: 12554526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
    J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New combination chemotherapy in refractory rhabdomyosarcoma of the prostate: a case report and review of the literature].
    Takeuchi T; Komeda H; Oguchi K; Ishihara S; Iwata H; Kanematsu M; Kuriyama M; Ban Y; Tanaka T
    Hinyokika Kiyo; 1987 Nov; 33(11):1899-905. PubMed ID: 2451411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
    Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
    Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
    Iwasaki Y; Ohsugi S; Takemura Y; Nagata K; Harada H; Nakagawa M
    Chest; 2002 Dec; 122(6):2249-52. PubMed ID: 12475873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas.
    Crist WM; Raney RB; Ragab A; Heyn R; Wharam M; Webber B; Johnston J; Beltangady M
    Med Pediatr Oncol; 1987; 15(2):51-7. PubMed ID: 3587117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
    J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
    Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
    Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
    Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report.
    Ishi Y; Yamaguchi S; Iguchi A; Cho Y; Ohshima J; Hatanaka KC; Takakuwa E; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg Pediatr; 2016 Jul; 18(1):41-5. PubMed ID: 26942266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor.
    Dagher R; Kreissman S; Robertson KA; Provisor A; Bergstein J; Burke K; Rodman JH; Emanuel D; Smith FO
    J Pediatr Hematol Oncol; 1998; 20(4):357-60. PubMed ID: 9703013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcoma of the head and neck in children.
    Coene IJ; Schouwenburg PF; Voûte PA; Marion J; Burgers V; Hilgers FJ
    Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):291-6. PubMed ID: 1382002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary leukemia in a child conceived using in vitro fertilization.
    Kim YD; Kim KJ; Lee YH
    Pediatr Int; 2008 Dec; 50(6):831-2. PubMed ID: 19067904
    [No Abstract]   [Full Text] [Related]  

  • 20. A Case of Adult Metastatic Rhabdomyosarcoma of the Prostate Cured by Long-Term Chemotherapy with Local Radiation.
    Konno M; Mitsuzuka K; Yamada S; Yamashita S; Kaiho Y; Ito A; Watanabe M; Arai Y
    Urol Int; 2019; 102(1):118-121. PubMed ID: 28427078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.